No Data
No Data
Keymed Biosciences Inc.'s (HKG:2162) 6.8% Loss Last Week Hit Both Individual Investors Who Own 37% as Well as Institutions
HK stocks surge | CanSino-B (02162) rises over 6%, signing an exclusive authorization agreement with Belenos for overseas authorization of two self-immune dual-antibody products.
Connoya-B (02162) is now up more than 6%, as of press time, up 5.88% to HKD 33.3, with a turnover of HKD 17.038 million.
What investment opportunities are available in Hong Kong and the United States stock markets as the Federal Reserve is about to cut interest rates?
This week, the reason for the Fed's interest rate cut has been further strengthened. Recently, a cluster of U.S. macroeconomic data has weakened. After the release of weak data last week such as unemployment rate, PMI, and durable goods orders, June CPI also weakened this week, boosting market expectations for Fed interest rate cuts. After the Fed started the interest rate cut cycle, real estate stocks, pharmaceutical stocks, and other interest rate-related sectors are expected to be favored by the market. Multiple data shows that the US economy is cooling down and US June CPI has fallen for the third consecutive month, indicating that the most severe inflation in 40 years in the US is steadily subsiding. Thursday's data shows that the US overall in June
Hong Kong stocks close (07.12) | The Hang Seng Index rose 2.59%, with strong performance from technology and mainland real estate stocks, and Longfor Group (00960) led the blue chips.
According to the Zhixun Finance APP, the U.S. CPI data for June boosted expectations of a rate cut in September, and the three major Hong Kong stock indices were strong again today, with the Hang Seng Index successfully surpassing the 18,000 level. At the close, the Hang Seng Index rose 2.59% or 461.05 points to 18,293.38 points, with a total daily turnover of 119.432 billion Hong Kong dollars; the Hang Seng China Enterprises Index rose 2.52% to 6,532.63 points; and the Hang Seng Tech Index rose 2.32% to 3,782.08 points. Looking at the entire week, the Hang Seng Index rose by 2.77%, the H Share Index rose by 2.36%, and the Hang Seng Tech Index rose by 5.15%. AXI International pointed out that the U.S. announced last night.
Hong Kong stock market anomaly: Kangnoah-B (02162) rose nearly 6% and signed an exclusive authorization agreement with Belenos, authorizing two self-immune double-resistant products overseas.
As learned from the Wisdom Finance app, Connoa-B (02162) is now up nearly 6%, and as of press time, it has risen 5.54%, at HKD 34.3, with a turnover of HKD 19.3711 million. On the news front, according to the Connoa Bio website, the company has reached a licensing agreement with Belenos for two independently developed bispecific antibodies, under the agreement terms: Connoa grants Belenos exclusive rights to develop, manufacture and commercialize clinical-stage drugs CM512 and CM536 globally (excluding Greater China). It is reported that as consideration, Connoa will receive a first payment of $15 million and
Keymed Biosciences Grants Beleons Out-License Agreement for Bispecific Antibodies
No Data